Establishment Labs Holdings Inc. ESTA
61.40 USD +0.33 (+0.54%)
At closeNov 3, 2026, 4:01 PM EST
61.40 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
60.56 Day range 62.91
47.23 52-week range 97.59
- YTD
- -15.75%
- 1 year
- +28.45%
News
benzinga.com BTIG Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $93 BTIG analyst Sam Eiber maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and lowers the price target from $103 to $93.
seekingalpha.com Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript
zacks.com Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.38 per share a year ago.
marketbeat.com What Establishment Labs (ESTA) Said on Its Q3 Earnings Call Establishment Labs NASDAQ: ESTA reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the…
benzinga.com Establishment Labs Hldgs Q3 2026 Earnings Call Transcript Establishment Labs Hldgs (NASDAQ:ESTA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com Establishment Labs Hldgs Q3 EPS $(0.35) Misses $(0.26) Estimate, Sales $71.993M Beat $66.460M Estimate Establishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.26) by 34.62 percent. This is a 7.89 percent increase over…
businesswire.com Establishment Labs® Reports Third Quarter 2026 Financial Results NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in…
benzinga.com TD Cowen Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $95 TD Cowen analyst Joshua Jennings maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and lowers the price target from $117 to $95.
zacks.com Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy? Establishment Labs (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
businesswire.com Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29 NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in…
benzinga.com TD Cowen Reiterates Buy on Establishment Labs Hldgs, Maintains $117 Price Target TD Cowen analyst Joshua Jennings reiterates Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and maintains $117 price target.
benzinga.com Establishment Labs Extends Master Supply Agreement With NuSil Technology To December 31, 2031 On October 14, 2026, Establishment Labs Holdings Inc. (the "Company"), through its wholly owned subsidiary, Establishment Labs, S.A. ("ELSA"), entered into Amendment No. 3 ("Amendment No. 3") to
defenseworld.net Contrasting Establishment Labs (NASDAQ:ESTA) & OraSure Technologies (NASDAQ:OSUR) Establishment Labs (NASDAQ: ESTA - Get Free Report) and OraSure Technologies (NASDAQ: OSUR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
benzinga.com Establishment Labs Hldgs Reports Q2 2026 Results: Full Earnings Call Transcript Establishment Labs Hldgs (NASDAQ:ESTA) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs…
businesswire.com Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants® NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in…
businesswire.com Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in…
defenseworld.net Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Brokerages Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine research firms that are presently covering the firm,…
seekingalpha.com Establishment Labs: Procedure Economics Strengthens The Bull Case Establishment Labs is leveraging FDA approval and U.S. market entry to drive higher-margin growth through procedure-based offerings like Preservé. Q2 2026 results showed 31.7% revenue growth, gross…
gurufocus.com A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture P
benzinga.com BTIG Reiterates Buy on Establishment Labs Hldgs, Maintains $103 Price Target BTIG analyst Sam Eiber reiterates Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and maintains $103 price target.
defenseworld.net Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Rating of “Moderate Buy” from Brokerages Shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine ratings firms that are currently covering the…
defenseworld.net Deutsche Bank AG Buys New Holdings in Establishment Labs Holdings Inc. $ESTA Deutsche Bank AG purchased a new position in shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA) in the second quarter, according to the company in its most recent filing with the Securities…
benzinga.com Citigroup Upgrades Establishment Labs Hldgs to Buy, Maintains Price Target to $92 Citigroup analyst Joanne Wuensch upgrades Establishment Labs Hldgs (NASDAQ:ESTA) from Neutral to Buy and maintains the price target from $92 to $92.- benzinga.com JP Morgan Maintains Overweight on Establishment Labs Hldgs, Raises Price Target to $95 JP Morgan analyst Allen Gong maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Overweight and raises the price target from $84 to $95.
seekingalpha.com Establishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call Transcript Establishment Labs Holdings Inc. (ESTA) Q2 2026 Earnings Call Transcript
benzinga.com Needham Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $95 Needham analyst Mike Matson maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $86 to $95.- benzinga.com BTIG Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $103 BTIG analyst Sam Eiber maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $96 to $103.
marketbeat.com Establishment Labs Q2 Earnings Call Highlights Establishment Labs NASDAQ: ESTA reported second-quarter revenue growth of 31.7% year over year, driven by continued rapid expansion in the United States, rising adoption of its Minimally Invasive…
zacks.com Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.57 per share a year ago.- benzinga.com Establishment Labs Hldgs Raises FY2026 Sales Guidance from $266.500M-$268.500M to $269.000M-$271.000M vs $267.480M Est Establishment Labs Hldgs (NASDAQ:ESTA) raises FY2026 sales outlook from $266.500 million-$268.500 million to $269.000 million-$271.000 million vs $267.480 million estimate.
businesswire.com Establishment Labs® Reports Second Quarter 2026 Financial Results NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in…- benzinga.com TD Cowen Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $117 TD Cowen analyst Joshua Jennings maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $95 to $117.
benzinga.com Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial Stock Jim Cramer recommends buying Howmet Aerospace Inc. (NYSE: HWM) and Farmers National Banc Corp. (NASDAQ: FMNB), and says Bending Spoons S.p.A. (NASDAQ: BSP) is a good software company. He is not a fan…
businesswire.com Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6 NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in…
defenseworld.net AlTi Global Inc. Makes New Investment in Establishment Labs Holdings Inc. $ESTA AlTi Global Inc. acquired a new stake in shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC.…- benzinga.com Mizuho Maintains Outperform on Establishment Labs Hldgs, Raises Price Target to $105 Mizuho analyst Anthony Petrone maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Outperform and raises the price target from $100 to $105.
- benzinga.com Citigroup Maintains Neutral on Establishment Labs Hldgs, Raises Price Target to $92 Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Neutral and raises the price target from $76 to $92.
- benzinga.com Establishment Labs Set To Join Russell 2000 Index, Effective June 29 Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, will be…
- benzinga.com BTIG Maintains Buy on Establishment Labs Hldgs, Raises Price Target to $90 BTIG analyst Sam Eiber maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from $88 to $90.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com 10 Health Care Stocks Whale Activity In Today's Session - benzinga.com Establishment Labs Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript
- benzinga.com Establishment Labs Hldgs Raises FY2026 Sales Guidance from $264.000M-$266.000M to $266.500M-$268.500M vs $264.984M Est Establishment Labs Hldgs (NASDAQ:ESTA) raises FY2026 sales outlook from $264.000 million-$266.000 million to $266.500 million-$268.500 million vs $264.984 million estimate.
- benzinga.com Establishment Labs Hldgs Q1 EPS $(0.45) Misses $(0.35) Estimate, Sales $59.877M Beat $57.495M Estimate Establishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.35) by 28.57 percent. This is a 35.71 percent increase over…
- benzinga.com Earnings Scheduled For February 24, 2026
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com This Figma Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - benzinga.com Earnings Scheduled For August 7, 2025
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Earnings Scheduled For May 7, 2025